RETINITIS PIGMENTOSA ASSOCIATED WITH IDIOPATHIC PANUVEITIS: TWO CASES REPORTS | ||||
Egyptian Journal of Clinical Ophthalmology | ||||
Article 1, Volume 1, Issue 2, December 2018, Page 43-47 PDF (640.24 K) | ||||
Document Type: Case reports: all new cases, rare cases, interesting cases can be reported. | ||||
DOI: 10.21608/ejco.2018.163036 | ||||
View on SCiNiTO | ||||
Authors | ||||
Radwan, A.1; Pachon, D.2; Mounir, A.3; Foster, S.4 | ||||
1Ophthalmology dept., Hotit Bani Tamim General Hospital, Riyadh, KSA | ||||
2Oftalmosanitas Uveitis Clinic, ClÌnica Colombia, Bogot·, Colombia | ||||
3Ophthalmology dept.., Faculty of Medicine, Sohag Univ., Sohag, Egypt | ||||
4Massachusetts Eye Research and Surgery Institution, Weston, MA, USA - Harvard Medical School, Boston, Massachusetts, USA | ||||
Abstract | ||||
We report two cases of retinitispigmentosa (RP) associated with Panuveitis in descriptive small case series. One case is RP associated with idiopathic panuveitis and the other oneis RP with multifocal choroiditis and panuveitis (MCP). These are rare entities and it is very unusual for them to coexist in a patient. The first case treated with pulsed intravenous Methotrexate (MTX) 50 mg every week then stopped when inflammation was quiet with no evidence of vasculitis or papillitis on fluoresce in angiogram. The second case was treated successfully with cellcept 2.5 grams daily along with vitamin A palmitate 15,000 IU daily. Conclusion: In patients with refractory panuveitis presenting with progressive decline in vision and visual field constriction, masquerade syndromes such as retinitis pigmentosa, must be excluded. | ||||
Keywords | ||||
Retinitis pigmentosa; Panuveitis; Methotrexate | ||||
Statistics Article View: 93 PDF Download: 349 |
||||